Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel lipase mutant enhances Pregabalin intermediate synthesis efficiency and purity. Cost-effective biocatalytic solution for pharmaceutical manufacturing supply chains.
Patent CN105734028A reveals high-efficiency epoxide hydrolase mutants for R-epichlorohydrin production, offering superior stability and supply chain reliability.
Patent CN111689881A reveals a catalytic sulfonation method for 4-chloro-2-fluoro-5-sulfamoylbenzoic acid, offering high purity and yield for reliable pharmaceutical intermediate supply chains.
Patent CN105734028A reveals mutant epoxide hydrolase for high-purity R-epichlorohydrin. Enhances stability and activity for reliable pharmaceutical intermediate supply chains.
Novel patent CN108659031A offers mild conditions for eribulin intermediate. Enhances supply chain reliability and reduces manufacturing costs for pharma partners.
Patent CN108026130B reveals enzyme mutant method for NMN. Low cost, high purity, scalable supply chain solution for global buyers.
Patent CN105602922A reveals efficient amidase catalysis for gabapentin intermediates. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalytic routes.
Patent CN114426508A reveals a novel one-pot synthesis for beta-carotene intermediates. Achieve >90% yield with simplified purification and reduced operational costs.
Patent CN111172213B reveals dual-enzyme tandem method for L-ABA. Offers cost reduction and supply chain reliability for pharma intermediates.
Patent CN104031063A reveals novel cyanation route for high-purity quinolone intermediates enabling cost reduction in API manufacturing and supply chain reliability.
Patent CN106282135A details a robust RrQR enzyme process for (R)-3-quinuclidinol, offering superior stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN114317472B details a novel biocatalytic route for (S)-nornicotine using immobilized imine reductase, offering superior purity and scalable manufacturing for pharmaceutical intermediates.
Novel patent CN107698523A offers high-yield Gefitinib preparation with reduced pollution and cost advantages for supply chain stability.
Patent CN113651864A reveals a safer synthesis route for Diquafosol Tetrasodium using inorganic ammonia, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
This patent details a novel biocatalytic route for sitagliptin intermediates offering high purity and yield. It enables significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Advanced catalytic hydrogenation process for anisidine production offering high purity, reduced waste, and scalable industrial solutions for global supply chains.
Patent CN114045271B reveals high-efficiency biocatalysis for Atazanavir intermediates. Discover cost reduction and supply chain reliability with immobilized enzyme technology.
Discover a green synthesis method for Cefodizime Sodium replacing toxic catalysts. Achieve >99.7% purity and significant cost reduction in pharmaceutical manufacturing.
Visible light photocatalysis method for beta-methoxy fatty acid esters. Metal-free, green process offering supply chain stability and cost efficiency for fine chemical manufacturing.
Patent CN113652408A reveals a novel carbonyl reductase mutant for efficient (R)-4-chloro-3-hydroxybutyric acid ethyl ester production, offering superior yield and green manufacturing advantages.